{"filings":[{"id":501436,"accession_number":"0001104659-26-063267","cik":2062583,"company_name":"MiniMed Group, Inc.","ticker":"MMED","form_type":"8-K","filed_at":"2026-05-18T21:09:45+00:00","items":["5.02","9.01"],"status":"ready","headline":"MiniMed director Brett Wall resigns; Scott Cundy appointed effective July 3, 2026","event_type":"leadership","confidence":"high","bullets":["Brett Wall (class II director) resigns effective July 3, 2026; no disagreement with management or board.","Scott Cundy appointed to fill vacancy as class II director, term expiring at 2027 annual meeting.","Cundy is Medtronic SVP and Chief Quality, Development, and Innovation Officer.","Cundy receives no board compensation while Medtronic is affiliate; thereafter standard non-employee director comp.","Appointment made under understanding that Mr. Wall's departure resulted from leaving Medtronic executive role."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97514,"accession_number":"0001104659-26-049045","cik":2062583,"company_name":"MiniMed Group, Inc.","ticker":"MMED","form_type":"8-K","filed_at":"2026-04-27T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"MiniMed parent Medtronic discloses unauthorized third-party data access; MiniMed IT not compromised","event_type":"cyber","confidence":"high","bullets":["Medtronic reported an unauthorized third party accessed data in certain IT systems on April 24, 2026.","Medtronic contained the incident, activated response protocols, and engaged external cybersecurity experts.","Medtronic found no impact on products, patient safety, operations, or financial reporting systems.","MiniMed is not aware of any compromise to its own IT systems from this incident.","MiniMed does not currently expect the incident to have a material impact on its business or financial results."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":112375,"accession_number":"0001104659-26-036112","cik":2062583,"company_name":"MiniMed Group, Inc.","ticker":"MMED","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"MiniMed adopts new executive severance plans: 2x pay on non-CIC termination, 3x on CIC","event_type":"other_material","confidence":"high","bullets":["Severance Plan for Executives provides lump sum equal to 2x base salary plus target annual bonus, plus 24 months COBRA on non-CIC termination.","Change of Control Severance Plan pays 3x base salary plus highest annual bonus, plus continued benefits for 3 years.","Plans cover named executive officers; equity vesting not continued except for retirement-eligible participants.","Plans effective March 23, 2026; excise tax gross-up reduced to better net-after-tax position if triggered."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":112374,"accession_number":"0001104659-26-034156","cik":2062583,"company_name":"MiniMed Group, Inc.","ticker":"MMED","form_type":"8-K","filed_at":"2026-03-25T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"MiniMed Flex insulin pump receives FDA clearance months early; $157M charge expected in Q4 FY2026","event_type":"regulatory","confidence":"high","bullets":["FDA cleared MiniMed Flex insulin pump several months earlier than expected, enabling earlier commercialization.","R&D was funded by Blackstone; Blackstone to earn greater of mid-to-high single digit royalty or min $157M payment.","MiniMed will record a one-time charge of $157 million in Q4 FY2026 for future payments due to Blackstone.","MiniMed Flex is a next-generation, smartphone-controlled insulin pump with a discreet design."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":112373,"accession_number":"0001628280-26-016018","cik":2062583,"company_name":"MiniMed Group, Inc.","ticker":"MMED","form_type":"8-K","filed_at":"2026-03-09T23:59:59+00:00","items":["1.01","2.01","2.03","3.02","3.03","5.03","5.02","7.01","9.01"],"status":"ready","headline":"MiniMed Group completes IPO, raises ~$560M; Medtronic retains 90% ownership","event_type":"other_material","confidence":"high","bullets":["IPO of 28M shares at $20/share; net proceeds ~$560M; $309M retained for corporate purposes, excess repays Medtronic intercompany debt.","Medtronic owns ~90% post-IPO; Separation completed via merger with KH2 and transfer of Medtronic's Diabetes business assets.","New 9-member board appointed with Kevin Lofton as Chair; officers include CEO Que Dallara, CFO Chad Spooner, etc.","$500M revolving credit facility established upon IPO closing for working capital and general corporate purposes.","Separation agreements filed governing tax, employee benefits, IP cross-licenses, transition services, and supply arrangements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":1.0,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}